News

Novartis to acquire Excellergy in deal worth up to $2bn

Apr 1, 2026 | News, Sales

Exl-111, a potential treatment included in the deal, is a central factor in many allergic diseases

Novo Nordisk’s Awiqli approved by US FDA as once-weekly basal insulin for patients with type 2 diabetes

Mar 31, 2026 | News, Regulatory

The insulin is designed as an alternative to daily basal insulin

Sandoz partners with Samsung Bioepis to develop up to five biosimilars

Mar 31, 2026 | News, Research

The agreement will expand the pipeline and builds on an existing partnership

Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment

Mar 30, 2026 | News, Research

Quotient’s somatic genomics platform technology will be used to develop the treatment

Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development

Mar 27, 2026 | News, Healthcare

The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct engagement with oncology, rare disease and cardiology patients

BMS’ Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma

Mar 26, 2026 | News, Regulatory

This type of cancer is the most common one diagnosed in teenagers

Eisai and Biogen’s new data shows Alzheimer’s patients choose to stay on Leqembi long-term

Mar 25, 2026 | News, Research

The findings were presented at the 20th International Conference on Alzheimer’s and Parkinson’s Diseases in Denmark

Scotland becomes first part of UK to screen all newborn babies for SMA

Mar 24, 2026 | News, Healthcare

The screening is part of a two-year evaluation funded by the Scottish government and Novartis

Novartis agrees on potential $3bn deal to buy Synnovations’s breast cancer treatment

Mar 23, 2026 | News, Sales

The oral drug is currently being evaluated for breast cancer and other advanced solid tumours in a phase 1/2 study

Department of Health and Social Care and partners launch new funding initiative

Mar 20, 2026 | News, Research

The DHSC, along with a UK government department and Wellcome, aims to tackle urgent infectious disease threats

Almirall celebrates new offices in China to advance innovation in dermatology

Mar 19, 2026 | News, Healthcare

The company’s R&D and commercial expertise represent valuable capabilities for future Chinese partners

Atrogi moves forward in phase 1 trial for oral candidate to improve metabolic and muscle health

Mar 18, 2026 | News, Research

First-in-class oral therapy mimics the effects of exercise with broad potential as a novel treatment for muscle-sparing weight loss

Novartis to acquire Excellergy in deal worth up to $2bn

Novo Nordisk’s Awiqli approved by US FDA as once-weekly basal insulin for patients with type 2 diabetes

Sandoz partners with Samsung Bioepis to develop up to five biosimilars

Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment

BMS’ Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma

Eisai and Biogen’s new data shows Alzheimer’s patients choose to stay on Leqembi long-term

Scotland becomes first part of UK to screen all newborn babies for SMA

Novartis agrees on potential $3bn deal to buy Synnovations’s breast cancer treatment

Department of Health and Social Care and partners launch new funding initiative

Almirall celebrates new offices in China to advance innovation in dermatology

Atrogi moves forward in phase 1 trial for oral candidate to improve metabolic and muscle health

Latest content

Latest intelligence

Quick links